Posted on 2/9/17
What's Behind Bioverativ's Spin-Out, and Should You Buy?
Biogen Inc. (NASDAQ:BIIB) recently completed spinning off its fast-growing hemophilia drugs into a new company, Bioverativ (NASDAQ:BIVV). The spinoff creates one of the most interesting players . . .
Posted on 2/9/17
Why Cara Therapeutics Stock Gained 57% in January
What happenedAccording to data from S&P Global Market Intelligence, shares of the clinical-stage biotech Cara Therapeutics (NASDAQ:CARA) gained a whopping 57% last month following its investor . . .
Posted on 2/9/17
Better Buy: Illumina, Inc. vs. Thermo Fisher Scientific
A revolution is going on right under our noses. Research organizations are discovering more about the human genome than ever before. Their findings are leading to . . .
Posted on 2/9/17
Atrius Health Recognized for Best Marketing Campaign at eHealthcare Leadership Awards
Atrius Health, an innovative nonprofit healthcare leader serving more than 675,000 adult and pediatric patients in eastern Massachusetts, was recently honored with a Platinum Award for . . .
Posted on 2/8/17
Harvard Pilgrim Health Care Foundation Awards Nearly $2.5M To More Than 900 Organizations In 2016
Since 1980, more than $140 Million Awarded to Nonprofits Working to Build Healthy Communities in Conn., Maine, Mass., and N.H.Harvard Pilgrim Health Care Foundation today announced that . . .
Posted on 2/8/17
athenahealth Upgraded: What You Need to Know
It's been five days since electronic medical records specialist athenahealth (NASDAQ:ATHN) reported its full-year 2016 earnings results, missing on revenue expectations but beating on Wall Street's . . .
Posted on 2/8/17
Novant Health Partners with Glytec
WALTHAM, Mass.--(BUSINESS WIRE)--Becoming a national leader in diabetes care is a commitment Novant Health, headquartered in Winston-Salem, North Carolina, will advance through a new partnership with . . .
Posted on 2/8/17
Marathon Pharmaceuticals and Italfarmaco Join cTAP
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Marathon Pharmaceuticals LLC and Italfarmaco SpA have joined the Collaborative Trajectory Analysis Project (cTAP), bringing their extensive knowledge and clinical expertise in Duchenne muscular . . .
Posted on 2/7/17
Boston Therapeutics Business Update
On February 1, 2017 Boston Therapeutics, Inc., headquartered in Lawrence MA, (OTCQB: BTHE) disclosed its restructured operations activity in a two part session covering the last . . .
Posted on 2/7/17
These 2 Factors Sent Bristol-Myers Squibb Co. Tumbling by 16% in January
What happenedShares of global drug giant Bristol-Myers Squibb (NYSE: BMY) were hammered in January, falling 16% according to data from S&P Global Market Intelligence. Once again, . . .
Posted on 2/7/17
Better Buy: Agenus Inc. vs. Alnylam Pharmaceuticals, Inc.
Agenus (NASDAQ:AGEN) and Alnylam Pharmaceuticals (NASDAQ:ALNY) are both clinical-stage biotechs developing drugs that hold the potential to make a big difference for patients. Shares of both . . .
Posted on 2/7/17
Why Sarepta Therapeutics, Inc. Stock Rose 13.2% in January
What happenedShares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a biotech that earned a controversial new drug approval last year, rose 13.2% last month, according to data from . . .
Posted on 2/7/17
Why Merrimack Pharmaceuticals Got Crushed 23.8% in January
What happenedAfter Merrimack Pharmaceuticals' (NASDAQ:MACK) board of directors provided investors with a blueprint to its reorganization, its shares lost 23.8% of their value last month, according . . .
Posted on 2/6/17
Gamma Medica Partners With Medical Imaging and Capital X-Ray
SALEM, N.H.--(BUSINESS WIRE)--Gamma Medica, a leader in molecular breast imaging (MBI) technology, today announced that it has partnered with Medical Imaging, Inc. and Capital X-Ray, Inc., . . .
Posted on 2/6/17
Athenahealth (ATHN) Q4 2016 Results - Earnings Call Transcript
athenahealth, Inc. (NASDAQ:ATHN)Q4 2016 Earnings CallFebruary 03, 2017 8:00 am ETExecutivesDana Quattrochi - athenahealth, Inc.Karl Stubelis - athenahealth, Inc.Jonathan S. Bush - athenahealth, Inc.AnalystsRoss Muken - . . .
Posted on 2/6/17
Athenahealth, Inc. Reports Slowing, but Solid, Growth in Q4
The third quarter of 2016 was a blowout for athenahealth (NASDAQ:ATHN). Earnings more than doubled year over year. The healthcare technology company announced its fourth-quarter results . . .
Posted on 2/5/17
Pulmatrix Announces Over $3.0 Million Registered Direct Offering
Pulmatrix, Inc., (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, today announced that it has entered into a . . .
Posted on 2/5/17
Axial Biotherapeutics Co-Founder Sarkis Mazmanian to Give Keynote Speech at the Microbiome in Health and Disease Keystone Symposium
BOSTON & PASADENA, Calif.--(BUSINESS WIRE)--Axial Biotherapeutics, a biotechnology company building a unique class of microbial-targeted CNS therapeutics, today announced that its Co-founder and California Institute of . . .
Posted on 2/3/17
ProEx Physical Therapy Appoints Melanie Deveikas as Staff Physical Therapist and Wellness Educator
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine announces
Posted on 2/3/17
What Could Make Biogen Crash?
Although Biogen Inc. (NASDAQ:BIIB) is one of the globe's biggest biotechs -- and it has the balance sheet to prove it -- it could face a . . .
Posted on 2/3/17
5 Drugmakers Battle Over the $10 Billion Hemophilia Market
Biogen spun-off of its long-lasting hemophilia drugs as a new company today, but that company -- Bioverativ (NASDAQ:BIVV) -- may struggle to deliver breakneck growth this . . .
Posted on 2/3/17
athenahealth, Inc. Reports Fourth Quarter and Full Year 2016 Results
WATERTOWN, Mass., Feb. 02, 2017 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ:ATHN), a leading provider of network-enabled services and point-of-care mobile applications for hospitals and ambulatory clients . . .
Posted on 2/3/17
Janssen Human Microbiome Institute Announces Multiple Collaborations
Janssen Research & Development, LLC (Janssen) announced today several new collaborations through its Janssen Human Microbiome Institute (JHMI) focused on advancing the discovery, development and commercialization . . .
Posted on 2/2/17
3 Pharmaceutical Stocks With Bigger Dividends Than Johnson & Johnson
If there were such a thing as the dividend stock hall of fame, Johnson & Johnson(NYSE:JNJ) would be in it. After all, the company increased its . . .
Posted on 2/2/17
“Best in KLAS” Report Names Iatric Systems No. 1 for Patient Privacy Monitoring for Third Consecutive Year
BOXFORD, Mass.--(BUSINESS WIRE)--Iatric Systems, Inc. today announced that its Security Audit Manager™ solution was named KLAS Category Leader in the Patient Privacy Monitoring category of the . . .
Boston
